Cargando…
Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab
Autores principales: | Yeh, Jennifer E., Tsiaras, William G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347515/ https://www.ncbi.nlm.nih.gov/pubmed/28337471 http://dx.doi.org/10.1016/j.jdcr.2017.01.012 |
Ejemplares similares
-
Vedolizumab (Entyvio®) for the Treatment of Pyoderma Gangrenosum in a Crohn’s Disease Patient
por: Groudan, Kevin, et al.
Publicado: (2021) -
Two cases of maggot debridement therapy in pyoderma gangrenosum
por: Din, Ryan S., et al.
Publicado: (2018) -
Pyoderma gangrenosum faciale in a patient with Crohn's disease
por: Arleo, Timothy, et al.
Publicado: (2020) -
Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
por: Lee, Hae Chan, et al.
Publicado: (2023) -
Granulomatous pyoderma gangrenosum of the genitalia in the absence of Crohn's disease
por: Kambil, Srinath M., et al.
Publicado: (2015)